• 1
    Parkin DM,Bray F,Ferlay J,Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74108.
  • 2
    Bouman A,Heineman MJ,Faas MM. Sex hormones and the immune response in humans. Human Reprod Update 2005; 11: 41123.
  • 3
    Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007; 28: 52174.
  • 4
    Olsson H,Olsson M,Ranstam J. Late age at first full-term pregnancy as a risk factor for women with malignant lymphoma. Neoplasma 1990; 37: 18590.
  • 5
    Kravdal O,Hansen S. Hogkin's disease: the protective effect of childbearing. Int J Cancer 1993; 55: 90914.
  • 6
    Glaser SL. Reproductive factors in Hodgkin's disease in women: a review. Am J Epidemiol 1994; 139: 23746.
  • 7
    Zahm S,Hoover R,Fraumeni J,Jr. Hodgkin's disease and parity. Int J Cancer 1995; 62: 3623.
  • 8
    Kravdal O,Hansen S. The importance of childbearing for Hodgkin's disease: new evidence from incidence and mortality models. Int J Epidemiol 1996; 25: 73743.
  • 9
    Zwitter M,Zakelj M,Kosmelj K. A case-control study of Hodgkin's disease and pregnancy. Br J Cancer 1996; 73: 24651.
  • 10
    Adami H-O,Tsaih S,Lambe M,Hsieh C,Adami J,Trichopolous D,Melbye M,Glimelius B. Pregnancy and risk of non-Hodgkin's lymphoma: a prospective study. Int J Cancer 1997; 70: 1558. [Erratum appears in Int J Cancer 1997, 71:705].
  • 11
    Tavani A,Pregnolato A,La Vecchia C,Franceschi S. A case-control study of reproductive factors and risk of lymphomas and myelomas. Leuk Res 1997; 21: 8858.
  • 12
    Lambe M,Hsieh CC,Tsaih SW,Adami J,Glimelius B,Adami HO. Childbearing and the risk of Hodgkin's disease. Cancer Epidemiol Biomarkers Prev 1998; 7: 8314.
  • 13
    Nelson R,Levine A,Bernstein L. Reproductive factors and risk of intermediate- or high-grade B-cell non-Hodgkin's lymphoma in women. J Clin Oncol 2001; 19: 13817.
  • 14
    Cerhan JR,Habermann TM,Vachon C,Putnam S,Zheng W,Potter JD,Folsom AR. Menstrual and reproductive factors and risk of non-Hodgkin lymphoma: the Iowa women's health study (United States). Cancer Causes Control 2002; 13: 1316.
  • 15
    Cerhan JR,Vachon C,Habermann TM,Ansell S,Witzig T,Kurtin P,Janney C,Zheng W,Potter JD,Sellers TA,Folsom AR. Hormone replacement therapy and risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 2002; 11: 146671.
  • 16
    Beiderbeck A,Holly EA,Sturkenboom M,Coebergh J,Stricker B,Leufkens H. No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands). Cancer Causes Control 2003; 14: 63944.
  • 17
    Fernandez E,Gallus S,Bosetti C,Franceschi S,Negri E,LaVecchia C. Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int J Cancer 2003; 105: 40812.
  • 18
    Glaser SL,Clarke CA,Nugent RA,Stearns CB,Dorfman RF. Reproductive factors in Hodgkin's disease in women. Am J Epidemiol 2003; 158: 55363.
  • 19
    Altieri A,Gallus S,Franceschi S,Fernandez E,Talamini R,La Vecchia C. Hormone replacement therapy and risk of lymphomas and myelomas. Eur J Cancer Prev 2004; 13: 34951.
  • 20
    Zhang Y,Holford TR,Leaderer B,Zahm SH,Boyle P,Morton LM,Zhang B,Zou K,Flynn S,Tallini G,Owens PH,Zheng T. Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control 2004; 15: 41928.
  • 21
    Zhang Y,Holford TR,Leaderer B,Boyle P,Zahm SH,Zhang B,Zou K,Morton LM,Owens PH,Flynn S,Tallini G,Zheng T. Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women. Am J Epidemiol 2004; 160: 76673.
  • 22
    Frisch M,Pedersen B,Wohlfahrt J,Hjalgrim H,Biggar R. Reproductive patterns and non-Hodgkin lymphoma risk in Danish women and men. Eur J Epidemiol 2006; 21: 6739.
  • 23
    Norgaard M,Poulsen A,Pedersen L,Gregersen H,Friis S,Ewertz M,Johnsen H,Sorensen H. Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish population-based cohort study. Br J Cancer 2006; 94: 133941.
  • 24
    Lee J,Bracci PM,Holly EA. Reproductive factors and hormone use in non-Hodgkin lymphoma (abstract #356). Am J Epidemiol 2007; 165( Suppl): S89.
  • 25
    Prescott J,Sullivan-Halley J,Clarke C,Cozen W,Bernstein L. Reproductive factors, body size, and risk of non-Hodgkin lymphoma subtypes in the California Teachers Study [abstract]. In: Proceedings of the Sixth AACR International Conference on Frontiers in Cancer Prevention Research, December 5–8, 2007. Philadelphia: AACR; 2007. Abstract B114.
  • 26
    Lee JS,Bracci PM,Holly EA. Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use. Am J Epidemiol 2008; 168: 27888.
  • 27
    Stefanick ML. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Foodand Drug Administration. Am J Med 2005; 118( Suppl. 12B): 6473.
  • 28
    Rothman N,Skibola CF,Wang SS,Morgan G,Lan Q,Smith MT,Spinelli JJ,Willett E,de Sanjose S,Cocco P,Berndt S,Brennan P, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006; 7: 2738.
  • 29
    Smedby KE,Vajdic CM,Falster M,Engels EA,Martinez-Maza O,Turner J,Hjalgrim H,Vineis P,Seniori Costantini A,Bracci PM,Holly EA,Willett E, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008; 111: 402938.
  • 30
    Weiss NS. Subgroup-specific associations in the face of overall null results: should we rush in or fear to tread? Cancer Epidemiol Biomarkers Prev 2008; 17: 12979.
  • 31
    Schatzkin A,Subar AF,Thompson FE,Harlan LC,Tangrea J,Hollenbeck AR,Hurwitz PE,Coyle L,Schussler N,Michaud DS,Freedman LS,Brown CC, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001; 154: 111925.
  • 32
    Lacey JV,Jr,Brinton LA,Leitzmann MF,Mouw T,Hollenbeck A,Schatzkin A,Hartge P. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst 2006; 98: 1397405.
  • 33
    Michaud DS,Midthune D,Hermansen S,Leitzmann MF,Harlan LC,Kipnis V,Schatzkin A. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Regist Manag 2005; 32: 705.
  • 34
    Percy C,Van Holten V,Muir C, eds. International classification of diseases for oncology,2nd edn. Geneva: World Health Organization, 1990.
  • 35
    Fritz A,Percy C,Jack A,Shanmugaratnam K,Sobin L,Parkin D, Whelan S, eds. International Classification of Diseases for Oncology,3rd edn. Geneva: World Health Organization, 2000.
  • 36
    Kleihues P,Sobin LH. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. In: Jaffe E,Harris N,Stein H,Vardiman J, eds. World Health Organization classification of tumours. Lyon: IARC Press, 2001. 352 p.
  • 37
    Morton LM,Turner JJ,Cerhan JR,Linet MS,Treseler PA,Clarke CA,Jack A,Cozen W,Maynadie M,Spinelli J,Seniori Costantini A,Rudiger T, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007; 110: 695708.
  • 38
    Gail M,Lubin JH,Rubinstein L. Likelihood calculations for matched case-control studies and survival studies with tied death times. Biometrika 1981; 68: 7037.
  • 39
    Rossouw J,Anderson G,Prentice R,LaCroix A,Kooperberg C,Stefanick ML,Jackson R,Beresford S,Howard B,Johnson KC,Kotchen J,Ockene J, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002; 288: 32133.
  • 40
    Medina KL,Strasser A,Kincade PW. Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 2000; 95: 205967.
  • 41
    Glaser SL,Clarke CA,Keegan THM,Gomez SL,Nugent RA,Topol B,Stearns CB,Stewart SL. Attenuation of social class and reproductive risk factor associations for Hodgkin lymphoma due to selection bias in controls. Cancer Causes Control 2004; 15: 7319.